Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Congress Approves Down Payment on Health Reform

The stimulus bill expands the healthcare safety net while boosting investment in health IT and comparative research.
Feb 19, 2009

The stimulus bill expands the healthcare safety net while boosting investment in health IT and comparative research.

Drug Prices Remain on the Cutting Board

Efforts to cut healthcare outlays will focus on drug costs, despite a drop in prescription sales.
Feb 2, 2009

Efforts to cut healthcare outlays will focus on drug costs, despite a drop in prescription sales.

FDA at a Crossroads

Will more resources and new leadership fix FDA, or is a major overhaul in order?
Jan 2, 2009

Will more resources and new leadership fix FDA, or is a major overhaul in order?

Industry Changes and Challenges

To expand coverage amidst the economic crisis, Obama will look for ways to cut healthcare costs.
Dec 2, 2008

To expand coverage amidst the economic crisis, Obama will look for ways to cut healthcare costs.

How Will the 2008 Election Results Affect the Preemption Debate?

The next president and the 111th Congress might change the extent of FDA's authority.
Dec 2, 2008

The next president and the 111th Congress might change the extent of FDA's authority.

FDA Collaborates on Nanotechnology Research

The US Food and Drug Administration seeks to understand nanotechnology better and exercise appropriate oversight over products that incorporate it.
Nov 2, 2008

The US Food and Drug Administration seeks to understand nanotechnology better and exercise appropriate oversight over products that incorporate it.

Nanotechnology Challenges FDA and Manufacturers

Policymakers weigh new rules to ensure the safety and quality of drugs made with tiny particles.
Nov 2, 2008

Policymakers weigh new rules to ensure the safety and quality of drugs made with tiny particles.

FDA Proposes Flexible Oversight for Quality Systems

Manufacturers seek real-world benefits from investment in QbD and risk-management strategies. This article contains bonus online-exclusive material.
Oct 2, 2008

Manufacturers seek real-world benefits from investment in QbD and risk-management strategies. This article contains bonus online-exclusive material.

Drug Imports under Scrutiny

FDA is taking several measures to ensure that imported drugs meet manufacturing standards.
Sep 2, 2008

FDA is taking several measures to ensure that imported drugs meet manufacturing standards.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here